This article was written by Follow Equity strategist + Co-PM Global Equities [Bernard Holdings]. Objective view on the directional bias of markets. Technical expertise...
Ginkgo Bioworks’ (NYSE:DNA) first quarter results were something of a mixed bag, with continued progression on a number of metrics offset by rising costs...
Hello and welcome to Financial Face-off, a MarketWatch column where we help you weigh a financial decision. Our columnist will give her verdict. Tell...
Although the recent sell-off in AT&T (NYSE:T) may have been unjustified, a long-term analysis of their continuing operations reveals a company that has done...
The fate of President Joe Biden’s unprecedented student loan forgiveness plan will be determined in a matter of weeks. The Supreme Court is expected...
Federal Bureau of Prisons Director Colette Peters took her position in August 2022 just as the agency was making headlines with staffing shortages, morale...
Coming on the heels of a profit warning last month, German medical technology and device company Carl Zeiss Meditec’s (OTCPK:CZMWF) half-year earnings letdown wasn’t...